Tuberous sclerosis (TS), or tuberous sclerosis complex (TSC), is a rare genetic condition that causes noncancerous, or benign, tumors to grow in your brain, other vital organs, and skin.

J Child Neurol. 2004;19(11):847-852.

These skin findings, together with pulmonary lymphangioleiomyomatosis, pointed to the diagnosis of tuberous sclerosis complex (TSC). TSC is a genetic disorder characterized by the presence of ...

Aim of the study: Tuberous sclerosis complex (TSC) is a genetic and multisystemic disorder that affects between 1/6’000 and 1/10’000 of newborns. Clinical criteria and/or genetic analysis establish ...

Radiprodil is under clinical development by Neurvati Neurosciences and currently in Phase II for Tuberous Sclerosis. According to GlobalData, Phase II drugs for Tuberous Sclerosis have a 71% phase ...

Cannabidiol is under clinical development by Jazz Pharmaceuticals and currently in Phase II for Schizophrenia.

Nov. 18, 2024 — Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help individuals with reduced working memory, as seen in ...

INR:9101. rummy block rules Science sub-journal: Gene therapy based on AAV viral vector is expected to treat tuberous sclerosis The country is about to launch a ...

Gene therapy based on AAV viral vector is expected to treat tuberous sclerosis Smooth muscle cell morphing in atherosclerosis prevents arterial plaque from rupturing Targeted drug Devimistat approved ...

Learn about pediatric low-grade glioma symptoms, causes, diagnosis, and treatment. Understand risk factors and prevention to ...

INR:3410. first betti number Pfizer submits latest stability data for COVID-19 vaccine, expected to increase storage/transportation flexibility Science sub-jou ...